TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
KLRS

Kalaris Therapeutics, Inc.

Healthcare · Biotechnology

2.90$ -4.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KLRS
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +450.7% +166.0% -22.7% -98.6% -14.5% +3,456.7% +2.7%
– +403.0% +183.8% -29.9% -98.5% -14.5% +3,456.7% +0.2%
– +144.7% +100.8% +64.4% -98.5% +3.6% +3,632.7% -17.1%
– +405.1% +182.6% -30.4% -98.8% +3.6% +3,632.7% -0.3%
– +85.4% -19.6% -88.9% – – – –
– +376.3% -0.2% +245.4% -44.3% +41.5% -89.2% +719.3%
– +143.7% +35.0% +207.9% -85.0% -30.7% +32.9% +85.4%
– – +5.3% +104.1% – – – –
– +311.8% +52.9% +768.2% -67.0% -14.4% -89.5% +418.6%
– – – – – – – –
– +463.5% +190.3% -36.2% -113.4% – – -30.4%
– – – – – – – –
– +0.0% -58.7% +133.4% +22.1% +35.7% +10.7% +204.8%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?